Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-003259
Filing Date
2018-04-27
Accepted
2018-04-27 06:08:31
Documents
9
Period of Report
2018-06-07
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2235408zdef14a.htm DEF 14A 948989
2 G429299.JPG g429299.jpg GRAPHIC 23328
3 G650180.JPG g650180.jpg GRAPHIC 8714
4 G245976.JPG g245976.jpg GRAPHIC 8525
5 G677153.JPG g677153.jpg GRAPHIC 32369
6 G144310.JPG g144310.jpg GRAPHIC 31749
7 G28372CGI001.GIF g28372cgi001.gif GRAPHIC 101625
8 G28372CII001.GIF g28372cii001.gif GRAPHIC 123782
9 G28372CKI001.GIF g28372cki001.gif GRAPHIC 175372
  Complete submission text file 0001047469-18-003259.txt   1647028
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS INC (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33497 | Film No.: 18780867
SIC: 2834 Pharmaceutical Preparations